Biosimilars Biosimilar uptake could unlock major savings for European healthcare systems Greater uptake of biosimilar medicines could deliver substantial savings for European health systems, but will require coordinated policies on procurement, prescribing and dispensing.
Inside EU Health Inside EU Health: Medicines for Europe appeals court decision; pharmaceutical exports support 926,000 EU jobs Generic makers appeal to fix tax on treatment; pharmaceutical exports supported 926 000 EU jobs
Critical Medicines Act Urgent action needed to stem critical medicine shortages Medicines for Europe says study highlights the need for reforms to secure patient access to medicines
Inside EU Health Inside EU Health: Climate inaction and health; ACT EU goes multilingual; and the US sets new rules for biosimilars Climate inaction and health; ACT EU goes multilingual; and the US sets news rules for biosimilars
